BridgeBio Pharma's top three insider shareholders as of May 30, 2026 are Global Investors Lp Viking (TenPercentOwner, 18.56Mn shares), Genetic Disorder L.P. Kkr (TenPercentOwner, 13.26Mn shares), Neil Kumar (Chief Executive Officer, 4.99Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Global Investors Lp Viking | - | 0 | 18,555,375 | 01 Jul, 2025 |
| Fred Hassan | - | 25,889 | 0 | 24 Jun, 2025 |
| Ronald J Daniels | - | 16,991 | 0 | 07 Nov, 2025 |
| Charles J Homcy | Chairman Of Pharmaceuticals | 916,674 | 0 | 12 Aug, 2025 |
| James C Momtazee | - | 95,080 | 0 | 24 Jun, 2025 |
| Richard H Scheller | - | 53,822 | 0 | 21 Feb, 2023 |
| Eric Aguiar | - | 6,589 | 0 | 24 Jun, 2025 |
| Randal W. Scott | - | 11,589 | 0 | 18 Feb, 2026 |
| Ali J. Satvat | - | 165,993 | 0 | 24 Jun, 2025 |
| Douglas A. Dachille | - | 0 | 20,000 | 16 Mar, 2022 |
| Andrew Lo | - | 14,089 | 50,583 | 19 Nov, 2025 |
| Neil Kumar | Chief Executive Officer | 0 | 4,994,133 | 13 Apr, 2026 |
| Jennifer E. Cook | - | 13,741 | 0 | 24 Jun, 2025 |
| Brian C Stephenson | Cfo And Treasurer | 102,464 | 0 | 27 Feb, 2025 |
| Genetic Disorder L.P. Kkr | - | 0 | 13,260,971 | 14 May, 2025 |
| Hannah Valantine | - | 7,465 | 0 | 12 Mar, 2026 |
| Andrea Ellis | - | 18,589 | 0 | 06 Mar, 2026 |
| Thomas Trimarchi | President And Cfo | 395,626 | 0 | 20 Mar, 2026 |
| Maricel Apuli | Chief Accounting Officer | 136,115 | 0 | 20 Mar, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 09 Apr, 2026 | Neil Kumar | Common Stock | D | 7,200 | $73.64 | 628,486 | I | S |
| 09 Apr, 2026 | Neil Kumar | Common Stock | D | 5,300 | $74.60 | 623,186 | I | S |
| 09 Apr, 2026 | Neil Kumar | Common Stock | D | 7,500 | $75.55 | 615,686 | I | S |
| 09 Apr, 2026 | Neil Kumar | Common Stock | D | 7,072 | $73.64 | 4,431,375 | I | S |
| 09 Apr, 2026 | Neil Kumar | Common Stock | D | 5,128 | $74.57 | 4,426,247 | I | S |
| 09 Apr, 2026 | Neil Kumar | Common Stock | D | 7,800 | $75.53 | 4,418,447 | I | S |
| 10 Apr, 2026 | Neil Kumar | Common Stock | D | 20,000 | $74.60 | 595,686 | I | S |
| 10 Apr, 2026 | Neil Kumar | Common Stock | D | 20,000 | $74.60 | 4,398,447 | I | S |
| 18 Mar, 2026 | Thomas Trimarchi | Common Stock | A | 59,041 | $0.00 | 395,626 | D | A |
| 18 Mar, 2026 | Thomas Trimarchi | Common Stock | A | 59,041 | $0.00 | 395,626 | D | A |
| 18 Mar, 2026 | Maricel Apuli | Common Stock | A | 14,170 | $0.00 | 136,115 | D | A |
| 18 Mar, 2026 | Thomas Trimarchi | Common Stock | A | 59,041 | $0.00 | 395,626 | D | A |
| 17 Mar, 2026 | Neil Kumar | Stock Option (Right to Buy) | A | 40,570 | $0.00 | 40,570 | D | A |
| 17 Mar, 2026 | Neil Kumar | Restricted Stock Units | A | 104,313 | $0.00 | 104,313 | D | A |
| 12 Mar, 2026 | Neil Kumar | Common Stock | D | 14,337 | $68.48 | 661,349 | I | S |
| 12 Mar, 2026 | Neil Kumar | Common Stock | D | 5,363 | $69.32 | 655,986 | I | S |
| 12 Mar, 2026 | Neil Kumar | Common Stock | D | 300 | $70.15 | 655,686 | I | S |
| 12 Mar, 2026 | Neil Kumar | Common Stock | D | 13,885 | $68.47 | 4,464,562 | I | S |
| 12 Mar, 2026 | Neil Kumar | Common Stock | D | 5,815 | $69.29 | 4,458,747 | I | S |
| 12 Mar, 2026 | Neil Kumar | Common Stock | D | 300 | $70.15 | 4,458,447 | I | S |